🌍·11h agoIndustry
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals
Publisher
M
Matinas BioPharma
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Matinas BioPharma
- Region
- 最新
- Scope
- Industry
- Published
- July 13, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on matinasbiopharma.com
Leave the platform to read the original full article on the publisher site.
Source: Matinas BioPharma
Scope: Industry
Related coverage
More related coverage
Interpharma Switzerland/9h ago
Medienmitteilung: Freihandelsabkommen Schweiz–UK setzt klares Zeichen für den Schutz des geistigen Eigentums
CPI (Healthcare Innovation)/10h ago
CPI and Illumion launch £480k project to advance battery electrode quality diagnostics
Certara/10h ago
When to Conduct Hepatic Impairment Studies and When Modeling May be Enough
Interpharma Switzerland/11h ago